ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320 | +19.0% | 58,720 | +46.6% | 0.00% | +100.0% |
| Q2 2023 | $269 | -60.4% | 40,062 | -47.9% | 0.00% | -75.0% |
| Q1 2023 | $679 | +207.2% | 76,854 | +165.4% | 0.01% | +166.7% |
| Q4 2022 | $221 | -99.9% | 28,962 | +22.6% | 0.00% | +50.0% |
| Q3 2022 | $168,000 | -59.0% | 23,623 | -53.4% | 0.00% | -50.0% |
| Q2 2022 | $410,000 | +17.1% | 50,678 | +100.8% | 0.00% | +33.3% |
| Q1 2022 | $350,000 | -47.8% | 25,239 | +5.7% | 0.00% | -25.0% |
| Q4 2021 | $670,000 | +85.6% | 23,876 | +124.9% | 0.00% | +100.0% |
| Q3 2021 | $361,000 | +15.7% | 10,614 | +38.8% | 0.00% | +100.0% |
| Q2 2021 | $312,000 | -70.5% | 7,645 | -70.9% | 0.00% | -83.3% |
| Q1 2021 | $1,059,000 | +789.9% | 26,301 | +1203.3% | 0.01% | +500.0% |
| Q4 2020 | $119,000 | -77.7% | 2,018 | -81.6% | 0.00% | -66.7% |
| Q3 2020 | $534,000 | +173.8% | 10,982 | +68.4% | 0.00% | +50.0% |
| Q4 2019 | $195,000 | -73.1% | 6,520 | -56.5% | 0.00% | -60.0% |
| Q2 2019 | $724,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |